True absolute contraindications to dental implants are genuinely rare. Far more patients self-disqualify over manageable risk factors than actually have a condition that rules out treatment entirely. Most candidacy content doesn’t help here, it’s a flat list with no sense of what’s actually serious and what isn’t.

This guide organizes every major factor into three tiers, absolute contraindications, manageable risk factors, and temporary or non-issues, and covers medical conditions rarely addressed anywhere: autoimmune disease, radiation therapy history, and blood-thinning medication.

Key Takeaways True absolute contraindications to dental implants are rare, profound immunosuppression, uncontrolled diabetes, IV bisphosphonates, and active cancer treatment among them, while far more common factors like smoking, periodontitis, and osteoporosis are manageable risk factors, not disqualifiers. A 2025 scoping review found predictable implant success even in patients on immunosuppressants for autoimmune disease, and current evidence supports continuing most blood thinners through implant surgery rather than stopping them.

What Are the True Absolute Contraindications to Dental Implants?

Genuine absolute contraindications are uncommon and generally include profound immunosuppression, uncontrolled diabetes, intravenous bisphosphonate therapy, bleeding disorders, a recent heart attack or stroke, active cancer treatment, and severe alcohol or drug dependency. Even within the clinical literature, evidence quality behind some of these as truly “absolute” is described as weak, this is a synthesized clinical framework, not a single definitive study.

Candidacy Factors by Tier Tiered structural chart. Absolute contraindications, rare: profound immunosuppression, uncontrolled diabetes, IV bisphosphonates, bleeding disorders, recent MI or stroke, active cancer treatment. Relative risk factors, common and manageable: smoking, periodontitis, osteoporosis, autoimmune disease, diabetes when controlled. Temporary factors, resolve on their own: pregnancy, acute infection, incomplete jaw growth. Source: aggregated clinical literature on medical contraindications to implant therapy, synthesized framework, evidence quality varies by factor. Absolute (rare) Profound immunosuppression Uncontrolled diabetes IV bisphosphonates Bleeding disorders Recent MI or stroke Active cancer treatment Relative (common, manageable) Smoking Periodontitis Osteoporosis Autoimmune disease Controlled diabetes Bruxism Temporary (resolve on their own) Pregnancy Acute infection Incomplete jaw growth
Most patients worrying about candidacy fall into the middle or right column, not the left one.

What Are the Common, Manageable Risk Factors?

Periodontitis carries the highest measured odds ratio for implant failure among common risk factors at 14.8, followed by bruxism at 2.19, smoking at 2.59, and diabetes at 1.78, figures already established in detail elsewhere on this site. None of these are disqualifiers on their own, they change the odds, and each has a practical management path.

Implant Failure Odds Ratio by Risk Factor Lollipop chart. Periodontitis: odds ratio 14.8. Smoking: odds ratio 2.59. Bruxism: odds ratio 2.19. Diabetes: odds ratio 1.78. Periodontitis carries a substantially higher odds ratio than the other three factors combined. Source: cross-referenced from this site’s risk-factor data, already cited in full in the digital-workflows failure-risk spoke. Periodontitis 14.8 Smoking 2.59 Bruxism 2.19 Diabetes 1.78
Periodontitis outranks smoking by more than 5-to-1, yet gets far less attention in most candidacy conversations.

[CITATION CAPSULE] Active periodontitis carries a far higher odds ratio for implant failure (14.8) than smoking (2.59) or diabetes (1.78), a genuinely underappreciated hierarchy since smoking gets far more attention in most candidacy discussions. Treating gum disease first, not just quitting smoking, is often the single highest-leverage step before implant treatment.

Practically, that means periodontal treatment before implant placement when active gum disease is present, smoking cessation support where possible (even a temporary pause around surgery helps), and glycemic control coordination with a physician for diabetic patients. For the full risk-factor data behind these figures, see How Digital Workflows Reduce Implant Failure Risk (With Data). For the actual HbA1c target, a smoking cessation timeline, and why vaping isn’t a safer alternative, see Dental Implants and Diabetes/Smoking: Risk Factors Explained.

Does Autoimmune Disease Rule Out Dental Implants?

No, generally not. A 2025 scoping review found dental implant treatment predictable with high survival at mid-term follow-up in patients with autoimmune disease, many of whom were on immunosuppressant therapy at the time of treatment (Hyldahl et al., Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review, Clinical Oral Implants Research, 2025).

That’s a more optimistic finding than most patients, and even some clinicians, assume. It doesn’t mean every autoimmune condition carries identical risk, case-by-case evaluation and coordination with the patient’s physician still matters, particularly around medication timing and disease activity at the time of surgery. But autoimmune disease alone isn’t the disqualifier it’s often treated as.

Is Radiation Therapy or Cancer Treatment a Contraindication?

Active cancer treatment and head or neck radiation require careful evaluation, not automatic exclusion. A study of 90 implants in 27 irradiated head and neck cancer patients found a mean radiation dose of 38 Gy as a critical threshold: 3-year implant survival was 100% below that dose versus 44.2% above it (Head & Neck, Risk Factor Analysis of Dental Implants in Irradiated Head and Neck Cancer Patients, 2022).

Implant Survival by Radiation Dose Threshold Bar chart. 3-year cumulative implant survival rate: 100 percent when mean radiation dose was below 38 Gray. 44.2 percent when mean radiation dose was above 38 Gray. Osteoradionecrosis occurred at a median dose of approximately 60 Gray, all cases in the failure group. Source: study of 90 implants in 27 irradiated head and neck cancer patients, Head and Neck, 2022. 100% Below 38 Gy 44.2% Above 38 Gy
Radiation dose, not radiation history alone, is the variable that actually predicts implant outcome here.

Osteoradionecrosis, bone tissue death linked to radiation exposure, occurred at a median dose of roughly 60 Gy in this study, exclusively among implants that had already failed. That’s part of why removable prostheses are sometimes preferred over implants specifically in higher-dose irradiated patients, and why a dental evaluation before radiotherapy begins is recommended when cancer treatment is being planned, to reduce the need for extractions afterward.

A healthcare professional in medical gloves hands a document to a patient in a clinic setting for signature and processing

Do I Need to Stop Blood Thinners Before Implant Surgery?

Usually not. A 2025 systematic review and meta-analysis found bleeding incidence after implant placement varied by medication, single-agent antiplatelet therapy showed the lowest risk at 1.6%, DOACs ranged from 0 to 6.1%, and warfarin ranged from 4.0 to 27.5% depending on procedural complexity, with every bleeding incident across the reviewed studies successfully managed using local hemostatic measures and no life-threatening events reported (Cureus, Postoperative Bleeding Complications Associated With Dental Implant Placement in Patients Receiving Antithrombotic Therapy, 2025).

[UNIQUE INSIGHT] Patients on blood thinners commonly assume they need to stop the medication before implant surgery. Current evidence points the other way: interrupting anticoagulation carries its own clotting risk, and local measures at the surgical site, not stopping the medication, are what actually manage bleeding risk for a procedure like implant placement.

Bleeding Incidence by Medication Type Grouped range chart. Single-agent antiplatelet therapy: 1.6 percent bleeding incidence, lowest risk. Direct oral anticoagulants (DOACs): 0 to 6.1 percent, range across studies. Warfarin: 4.0 to 27.5 percent, depending on procedural complexity. All bleeding incidents in the reviewed studies were successfully managed with local hemostatic measures, no life-threatening events reported. Source: systematic review and meta-analysis, Cureus, 2025. Antiplatelet (single) 1.6% DOACs 0-6.1% Warfarin 4.0-27.5%
All ranges are manageable with local measures alone, none required stopping the medication in the reviewed studies.

That said, dual antiplatelet therapy (two blood-thinning medications combined) showed meaningfully higher bleeding rates in the same review, up to 61% for moderate bleeding, a genuine exception worth flagging directly with your prescribing physician and surgeon together before any procedure.

What About Age and Bone Volume?

Age alone isn’t a disqualifier, and bone volume is something a scan measures directly rather than something to guess at from age or how long a tooth has been missing. We’ve covered the exact age-survival data and Hounsfield-unit bone density classification in full elsewhere, specific to full-arch cases, and the CBCT scan that actually measures bone volume for any case is explained here.

[PERSONAL EXPERIENCE] The medical history questions that come up most often at a first consultation aren’t about age. They’re about medication, “am I on the wrong pills for this,” more than “am I too old for this.” Both questions usually have a more reassuring answer than the patient expects.

[ORIGINAL DATA] We’re tracking, in general terms, how often a patient arrives having self-disqualified over a condition that turns out not to be a barrier at all. We’re not ready to publish a specific number yet, but it’s a pattern worth documenting properly.

Frequently Asked Questions

What medical conditions disqualify you from dental implants?

True absolute contraindications are uncommon: profound immunosuppression, uncontrolled diabetes, IV bisphosphonate therapy, bleeding disorders, a recent heart attack or stroke, and active cancer treatment. Most other conditions are manageable risk factors, not disqualifiers.

Can autoimmune disease patients get dental implants?

Generally yes. A 2025 scoping review found predictable, high-survival implant outcomes at mid-term follow-up in autoimmune disease patients, many on immunosuppressant therapy, though case-by-case evaluation still matters.

Is radiation therapy a contraindication for dental implants?

It’s dose-dependent, not automatic. One study found 100% 3-year implant survival below a 38 Gy mean radiation dose versus 44.2% above it, with osteoradionecrosis concentrated at higher doses.

Do I need to stop blood thinners for dental implant surgery?

Usually not. Current evidence supports continuing most anticoagulant or antiplatelet medication through implant placement, managing bleeding risk with local measures rather than interrupting the medication.

Does smoking automatically disqualify me?

No. Smoking roughly doubles complication and failure risk (odds ratio 2.59), a manageable risk factor, not a disqualifier, and notably lower than the risk carried by untreated periodontitis (odds ratio 14.8).

Conclusion

True absolute contraindications to dental implants are rare. Most conditions patients worry about, smoking, periodontitis, osteoporosis, autoimmune disease, even most blood-thinning medication, are manageable risk factors requiring coordination, not disqualification. Radiation history and certain cancer treatments are the clearer exceptions, and even there, the actual dose and timing matter more than the history alone.

A CBCT-based consultation, with a full medical history review, is the only way to know exactly where a specific case stands. For the broader orientation this fits into, see Dental Implants Explained: The Complete Patient Guide.

Sources